SuperworthDrugs Made In America Acquisition II EPS DMII
Diluted earnings per share by quarter and over the last twelve months, from 2025.
- Last 12 months, to Jun 30, 2026
- $0.94
- Latest quarter, Q2 FY26
- $0.32
- Fiscal year 2025
- $0.30
Drugs Made In America Acquisition II's earnings per share was $0.94 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was $0.32.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.30 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.32 | n/a | $0.94 | |
| Q1 FY26 | $0.32 | n/a | $0.62 | |
| Q4 FY25 | $0.30 | n/a | $0.30 | |
| Q3 FY25 | $0.00 | n/a | n/a | |
| Q2 FY25 | $0.00 | n/a | n/a | |
| Q1 FY25 | $0.00 | n/a | n/a |
Against its peers
Companies in Financial Services nearest Drugs Made In America Acquisition II's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| DMIIDrugs Made In America Acquisition II | $0.94 | |
| PRTHPriority Technology | $0.69 | +165% a year |
| TCBXThird Coast Bancshares | $3.94 | +23% a year |
| ACNBAcnb | $5.27 | +96% a year |
| CBNKCapital Bancorp | $3.40 | +27% a year |
| CARECarter Bankshares | $5.81 | +327% a year |
| BHBBar Harbor Bankshares | $2.96 | +15% a year |
| RRBIRed River Bancshares | $6.95 | +23% a year |
| MSBIMidland States Bancorp | $1.56 | |
| GCBCGreene County Bancorp | $2.41 | +32% a year |
| FBIZFirst Business Financial Services | $6.56 | +17% a year |
| Peer median | $3.67 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Drugs Made In America Acquisition II
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.